Evidence map›Paper›PMID 40487928›Full record

ArticleBioinformatics advances2025

Identifying core genes in keloid and investigating immune infiltration and pan-cancer associations using eQTL and machine learning.

Xiaoyuan He, Yang Song

Abstract read
In one paragraph

Article in Bioinformatics advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Xiaoyuan HeSecond Clinical College, Changzhi Medical College, Changzhi, Shanxi 046000, China.ORCID https://orcid.org/0009-0000-8193-4670
Yang SongLaboratory Animal Center, Changzhi Medical College, Changzhi, Shanxi, 046000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Motivation: Keloid is a fibroproliferative skin disorder characterized by excessive fibroblast proliferation and abnormal extracellular matrix accumulation. It manifests as continuous growth, redness, itching, and pain, with a high recurrence rate. The pathogenesis of keloid is complex, with genetics and gene mutations increasingly recognized as critical risk factors. This condition exhibits familial predisposition and clustering, with individuals of darker skin tones at greater risk. To elucidate the genetic factors underlying keloid development, this study integrates bioinformatics and Mendelian randomization (MR) approaches to identify core genes associated with keloid, providing novel insights into its pathogenesis, treatment, and prognosis. Results: Bioinformatics and Mendelian randomization analyses identified two intersecting genes, CCND2 and KLF4, as core genes associated with keloid. MR analysis revealed that CCND2 is causally associated with keloid [inverse variance weighted (IVW) odds ratio (OR): 1.410; 95% confidence interval (CI): 1.001-1.985, Availability and implementation: Firstly, bioinformatics analysis identified differentially expressed genes (DEGs) from the keloid GEO datasets. Secondly, MR was applied to eQTL and keloid GWAS datasets to identify candidate genes. Overlapping genes were derived by intersecting DEGs with MR candidate genes. Causal relationships between overlapping genes and keloids were analyzed using five MR methods, identifying core genes significantly associated with keloid pathogenesis. Cochran's Q test and MR-Egger intercept analysis evaluated heterogeneity and pleiotropy in MR results. GO, KEGG, and GSEA enrichment analyses were conducted to explore core gene functions. Finally, validation and TCGA pan-cancer analyses were conducted on the core genes.

Identifiers

PMID40487928
PMCPMC12145169

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.